Early Reduction of Lesion Volume is Associated with Complete Early Recanalization in Stroke Patients Treated with Intravenous tissue-Plasminogen Activator Therapy

被引：0
|
作者：
Sakamoto, Yuki [1 ]
Iguchi, Yasuyuki [1 ]
Watanabe, Masao [1 ]
Iwanaga, Takeshi [1 ]
Matsumoto, Noriko [1 ]
Shibazaki, Kensaku [1 ]
Kimura, Kazumi [1 ]
机构：
[1] Kawasaki Med Sch, Kurashiki, Okayama, Japan
来源：
STROKE | 2011年 / 42卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E167 / E167
页数：1
相关论文
共 50 条
  • [21] EARLY THROMBOLYSIS BY RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR IS BENEFICIAL TO THE ISCHEMIC MYOCARDIUM
    HIGO, K
    KARASAWA, A
    KUBO, K
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1992, 15 (01): : 33 - 37
  • [22] Redefining Early Neurological Improvement After Intravenous Tissue Plasminogen Activator Treatment of Stroke
    Agarwal, Shashank
    Cutting, Shawna
    Mac Grory, Brian
    Burton, Tina
    Jayaraman, Mahesh
    McTaggart, Ryan
    Reznik, Michael
    Scher, Erica
    Chang, Andrew D.
    Frontera, Jennifer
    Lord, Aaron
    Rostanski, Sara
    Ishida, Koto
    Torres, Jose
    Furie, Karen
    Yaghi, Shadi
    STROKE, 2020, 51
  • [23] DELAYED TISSUE-PLASMINOGEN ACTIVATOR THERAPY IN A RABBIT MODEL OF THROMBOEMBOLIC STROKE - COMMENT
    WEIR, BKA
    NEUROSURGERY, 1995, 36 (06) : 1177 - 1177
  • [24] Quantification of Thrombus Hounsfield Units on Noncontrast CT Predicts Stroke Subtype and Early Recanalization after Intravenous Recombinant Tissue Plasminogen Activator
    Puig, J.
    Pedraza, S.
    Demchuk, A.
    Daunis-i-Estadella, J.
    Termes, H.
    Blasco, G.
    Soria, G.
    Boada, I.
    Remollo, S.
    Banos, J.
    Serena, J.
    Castellanos, M.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2012, 33 (01) : 90 - 96
  • [25] Admission Leukocytosis Is Not Associated with Early Response to Tissue Plasminogen Activator in Patients with Acute Ischemic Stroke
    Gillette, Michael
    Siegler, James
    Kumar, Andre
    Boehme, Amelia
    Martin-Schild, Sheryl
    Albright, Karen
    NEUROLOGY, 2012, 78
  • [26] Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients
    Takeuchi, Satoru
    Wada, Kojiro
    Nagatani, Kimihiro
    Otani, Naoki
    Osada, Hideo
    Nawashiro, Hiroshi
    ACTA NEUROCHIRURGICA, 2012, 154 (01) : 87 - 87
  • [27] Development of orolingual angioedema in ischemic stroke patients treated with intravenous tissue plasminogen activator
    Khaja, Aslam M.
    Merrick, Michael T.
    Noser, Elizabeth A.
    Albright, Karen C.
    Gonzales, Nicole R.
    Barreto, Andrew D.
    Martin-Schild, Sheryl
    Hallevi, Hen
    Illoh, Kachikwu
    Shaltoni, Hashem M.
    Grotta, James C.
    STROKE, 2007, 38 (02) : 506 - 506
  • [28] The relationship between serum bilirubin levels and early neurological improvement in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator
    Demir, Aysegul
    Eren, Fettah
    NEUROLOGY ASIA, 2022, 27 (01) : 83 - 92
  • [29] Seasonal difference in the incidence of ischemic stroke patients treated with intravenous tissue plasminogen activator
    Kodera, Y.
    Yutani, S.
    Mizuma, A.
    Uesugi, T.
    Tokuoka, K.
    Ohnuki, Y.
    Nagata, E.
    Takahashi, W.
    Takizawa, S.
    Kitagawa, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 67 - 67
  • [30] Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients
    Satoru Takeuchi
    Kojiro Wada
    Kimihiro Nagatani
    Naoki Otani
    Hideo Osada
    Hiroshi Nawashiro
    Acta Neurochirurgica, 2012, 154 : 87 - 87
12345